Nguyen Diem 4

What Happened
Nguyen Diem, a director of Verrica Pharmaceuticals (VRCA), received a derivative award for 16,000 shares on June 5, 2026. The grant is reported at $0.00 per share (no cash paid). This was an award/grant (not a market purchase or sale) disclosed on a Form 4 filed June 9, 2026.

Key Details

• Transaction date: June 5, 2026; Form 4 filed June 9, 2026.
• Award: 16,000 derivative shares reported at $0.00 per share (no cash consideration reported).
• Ownership after transaction: not specified in the provided filing.
• Footnote: the underlying option vests in 12 equal monthly installments beginning July 5, 2026 and will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director.
• No indication in the filing that shares were exercised or sold.

Context
This filing reports a time‑based equity award (a derivative/option grant) to a non-executive director. Such awards are commonly used for director compensation and vest over time; they are not an immediate market buy or sell and do not itself indicate the director traded stock for cash.